| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |